| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Davison D, Parrott AC |
Ecstasy (MDMA) in Recreational Users: Self-Reported Psychological and ... |
Human Psychopharmaco... |
1997 |
| Parrott AC, Stuart M |
Ecstacy (MDMA), amphetamine, and LSD: Comparative mood profiles in rec... |
Human Psychopharmaco... |
1997 |
| Parrott AC, Lasky J |
Ecstasy (MDMA) effects upon mood and cognition: before, during and aft... |
Psychopharmacology (... |
1998 |
| Parrott AC, Lees A, Garnh... |
Cognitive performance in recreational users of MDMA of 'ecstasy': evid... |
J Psychopharmacol (O... |
1998 |
| Parrott AC |
The psychobiology of MDMA or 'ecstasy': symposium arranged by the Psyc... |
J Psychopharmacol (O... |
1998 |
| Parrott AC, Sisk E, Turne... |
Psychobiological problems in heavy `ecstasy' (MDMA) polydrug users |
Drug Alcohol Depend |
2000 |
| Parrott AC |
Human research on MDMA (3,4-Methylene-dioxymethamphetamine) neurotoxic... |
Neuropsychobiology |
2000 |
| Turner JJD, Parrott AC |
'Is MDMA a Human Neurotoxin?': Diverse Views from the Discussants |
Neuropsychobiology |
2000 |
| Parrott AC |
Human psychopharmacology of ecstasy; A review of 15 years of empirical... |
Hum Psychopharm Clin... |
2001 |
| Fox HC, Toplis AS, Turner... |
Auditory verbal learning in drug-free Ecstasy polydrug users |
Hum Psychopharm Clin... |
2001 |
| Fox HC, Parrott AC, Turne... |
Ecstasy use: cognitive deficits related to dosage rather than self-rep... |
J Psychopharmacol |
2001 |
| Soar K, Turner JJD, Parr... |
Psychiatric disorders in Ecstasy (MDMA) users: a literature review foc... |
Hum Psychopharmacol ... |
2001 |
| Parrott AC, Milani RM, Pa... |
Recreational ecstasy/MDMA and other drug users from the UK and Italy: ... |
Psychopharmacology (... |
2001 |
| Parrott AC |
Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic ne... |
Pharmacol Biochem Be... |
2002 |
| Fox HC, McLean A, Turner ... |
Neuropsychological evidence of a relatively selective profile of tempo... |
Psychopharmacology (... |
2002 |
| Parrott AC, Buchanan T, S... |
Ecstasy/MDMA attributed problems reported by novice, moderate and heav... |
Hum Psychopharmacol |
2002 |
| Parrott AC, Buchanan T, H... |
Parkinson's disorder, psychomotor problems and dopaminergic neurotoxic... |
Psychopharmacology (... |
2003 |
| Sumnall HR, Jerome L, Dob... |
Response to: Parrott AC, Buchanan T, Heffernan TM, Scholey A, Ling J, ... |
Psychopharmacology (... |
2003 |
| Sumnall HR, Jerome L, Dob... |
Response to: Parrott AC, Buchanan T, Heffernan TM, Scholey A, Ling J, ... |
Psychopharmacology (... |
2004 |
| Parrott AC, Rodgers J, Bu... |
The reality of psychomotor problems, and the possibility of Parkinson'... |
Psychopharmacology (... |
2004 |
| Parrott AC |
Is ecstasy MDMA? A review of the proportion of ecstasy tablets contain... |
Psychopharmacology (... |
2004 |
| Scholey AB, Parrott AC, B... |
Increased intensity of Ecstasy and polydrug usage in the more experien... |
Addict Behav |
2004 |
| Milani RM, Parrott AC, Tu... |
Gender differences in self-reported anxiety, depression, and somatizat... |
Addict Behav |
2004 |
| Parrott AC |
Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetam... |
J Psychopharmacology |
2005 |
| Milani RM, Parrott AC, Sc... |
Pattern of cannabis use in ecstasy polydrug users: moderate cannabis u... |
Hum Psychopharmacol |
2005 |
| Parrott AC, Gibbs A, Scho... |
MDMA and methamphetamine: some paradoxical negative and positive mood ... |
Psychopharmacology (... |
2011 |
| Parrott AC |
Residual neurocognitive features of ecstasy use: a re-interpretation o... |
Addiction |
2011 |
| Parrott AC |
MDMA, serotonergic neurotoxicity, and the diverse functional deficits ... |
Neurosci Biobehav Re... |
2013 |
